Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-10-28

FDA Approved: FEMARA — Supplemental Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

The FDA approved a supplemental application for FEMARA (letrozole) from Novartis Pharmaceuticals Corporation. The approval indicates an updated modification to …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FEMARA (letrozole)

Snippet

SUPPL AP for FEMARA (LETROZOLE)